Clinical trial
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer…
NCT00021294 · University of Arizona, Other · Completed
Key facts
| NCT number | NCT00021294 |
|---|---|
| Title | Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis |
| Official title | Phase IIB Randomized, Double-Blinded, Placebo Controlled Study to Evaluate the Safety and Efficacy of Topical Difluoromethylornithine (DFMO) With and Without a Topical Corticosteroid Cream (Triamcinolone 0.1%) in the Therapy of Actinic Keratoses (AK) on the Forearms |
| Lead sponsor | University of Arizona, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-melanomatous Skin Cancer, Precancerous/Nonmalignant Condition |
| Intervention type | Drug |
| Interventions | eflornithine, triamcinolone |
| Start date | May 1, 2001 |
| Primary completion | Jun 1, 2002 |
| Completion | Jun 1, 2002 |
| First posted | Feb 16, 2004 |
| Last update posted | Sep 11, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: